ApoptoCyte

**ApoptoCyte** is an experimental apoptosis-based regenerative medicine product platform developed by Therapeutic Solutions International. Public descriptions indicate it is generated by inducing apoptosis in mesenchymal stem cells, isolating apoptotic body vesicles, and using this material as a therapeutic product or as an enhancer of mesenchymal stem cell activity, particularly in connection with the company's JadiCell program. Reported preclinical work has focused on pulmonary disease such as chronic obstructive pulmonary disease and on cognitive dysfunction, but there is no clear evidence from authoritative public sources of regulatory approval, established clinical efficacy, or a fully characterized molecular mechanism in humans.

Brand names

ApoptoCyte

Other names

ApoptoCyte procedureApoptocyte